Rapid and Sensitive Detection of Shiga Toxin-Producing Escherichia coli from Nonenriched Stool Specimens by Real-Time PCR in Comparison to Enzyme Immunoassay and Culture
暂无分享,去创建一个
[1] J. Rosenblatt,et al. Comparison of Real-Time PCR for Detection of the tcdC Gene with Four Toxin Immunoassays and Culture in Diagnosis of Clostridium difficile Infection , 2008, Journal of Clinical Microbiology.
[2] E. Boedeker,et al. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections , 2008, Current opinion in gastroenterology.
[3] T. F. Smith,et al. Quantitative real-time polymerase chain reaction for evaluating DNAemia due to cytomegalovirus, Epstein-Barr virus, and BK virus in solid-organ transplant recipients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] Y. V. van Duynhoven,et al. Evaluation of 5'-nuclease and hybridization probe assays for the detection of shiga toxin-producing Escherichia coli in human stools. , 2007, Journal of microbiological methods.
[5] F. Scheutz,et al. Subtyping Method for Escherichia coli Shiga Toxin (Verocytotoxin) 2 Variants and Correlations to Clinical Manifestations , 2007, Journal of Clinical Microbiology.
[6] C. Sears,et al. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] H. Karch,et al. Enterohaemorrhagic Escherichia coli in human medicine. , 2005, International journal of medical microbiology : IJMM.
[8] P. Tarr,et al. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.
[9] S. Tzipori,et al. Antibody Therapy in the Management of Shiga Toxin-Induced Hemolytic Uremic Syndrome , 2004, Clinical Microbiology Reviews.
[10] T. Cleary. The role of Shiga-toxin-producing Escherichia coli in hemorrhagic colitis and hemolytic uremic syndrome. , 2004, Seminars in pediatric infectious diseases.
[11] R. Thomson,,et al. Evaluation of Performance and Potential Clinical Impact of ProSpecT Shiga Toxin Escherichia coli Microplate Assay for Detection of Shiga Toxin-Producing E. coli in Stool Samples , 2004, Journal of Clinical Microbiology.
[12] A. Siitonen,et al. Clinical Escherichia coli Strains Carrying stx Genes: stx Variants and stx-Positive Virulence Profiles , 2002, Journal of Clinical Microbiology.
[13] C. Park,et al. Importance of Testing Stool Specimens for Shiga Toxins , 2002, Journal of Clinical Microbiology.
[14] S. Kehl. Role of the Laboratory in the Diagnosis of Enterohemorrhagic Escherichia coli Infections , 2002, Journal of Clinical Microbiology.
[15] N. W. Davis,et al. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7 , 2001, Nature.
[16] M. Louie,et al. PCR Detection of Escherichia coli O157:H7 Directly from Stools: Evaluation of Commercial Extraction Methods for Purifying Fecal DNA , 2000, Journal of Clinical Microbiology.
[17] Craig S. Wong,et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. , 2000, The New England journal of medicine.
[18] A. Caprioli,et al. A New Shiga Toxin 2 Variant (Stx2f) fromEscherichia coli Isolated from Pigeons , 2000, Applied and Environmental Microbiology.
[19] S. Lauwers,et al. Identification of New Verocytotoxin Type 2 Variant B-Subunit Genes in Human and Animal Escherichia coliIsolates , 1998, Journal of Clinical Microbiology.
[20] K. Bettelheim. Reliability of CHROMagar® O157 for the detection of enterohaemorrhagic Escherichia coli (EHEC) O157 but not EHEC belonging to other serogroups , 1998, Journal of applied microbiology.
[21] B. Souweine,et al. Non-O157:H7 Stx2-Producing Escherichia coli Strains Associated with Sporadic Cases of Hemolytic-Uremic Syndrome in Adults , 1998, Journal of Clinical Microbiology.
[22] S. Ostroff,et al. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. , 1989, The Journal of infectious diseases.
[23] Laboratory-confirmed non-O157 Shiga toxin-producing Escherichia coli--Connecticut, 2000-2005. , 2007, MMWR. Morbidity and mortality weekly report.
[24] Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach--United States, September 2006. , 2006, MMWR. Morbidity and mortality weekly report.
[25] Importance of culture confirmation of shiga toxin-producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis--New York and North Carolina, 2005. , 2006, MMWR. Morbidity and mortality weekly report.
[26] A. Friedrich,et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.
[27] H. M.P.,et al. Multistate outbreak of Escherichia coli O157:H7 infections associated with eating ground beef--United States, June-July 2002. , 2002, MMWR. Morbidity and mortality weekly report.
[28] F. Jacobs,et al. Hemolytic uremic syndrome in Belgium: incidence and association with verocytotoxin-producing Escherichia coli infection. , 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[29] J. Paton,et al. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. , 1998, Journal of clinical microbiology.
[30] Update: multistate outbreak of Escherichia coli O157:H7 infections from hamburgers--western United States, 1992-1993. , 1993, MMWR. Morbidity and mortality weekly report.